CapsoVision, Inc. - Common Stock (CV)
4.5400
+0.1900 (4.37%)
NASDAQ · Last Trade: Jul 29th, 6:09 PM EDT
Detailed Quote
| Previous Close | 4.350 |
|---|---|
| Open | 4.300 |
| Bid | 4.450 |
| Ask | 4.540 |
| Day's Range | 4.300 - 4.600 |
| 52 Week Range | 3.500 - 5.078 |
| Volume | 86,272 |
| Market Cap | - |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 707,170 |
Chart
News & Press Releases
InvestorNewsBreaks – Roth Capital Partners Serves as Joint Book-Running Manager for CapsoVision (NASDAQ: CV) $27.5 Million IPO
Roth Capital Partners acted as joint book-running manager for the initial public offering of CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company focused on AI-powered capsule endoscopy solutions. CapsoVision offered 5,500,000 shares of common stock at $5.00 per share, with gross proceeds totaling approximately $27.5 million before deductions. The shares began trading on the Nasdaq Capital Market on July 2, 2025, under the ticker symbol “CV.” The company also granted underwriters a 30-day option to purchase up to an additional 825,000 shares at the IPO price.
Via Investor Brand Network · July 24, 2025